Appearing as a significant breakthrough in the battle against obesity, the drug is attracting considerable interest . It combines properties of two established GLP-1 receptor agonists, semaglutide , and an unique glucose-dependent hormonal component. Initial patient data have indicated substantial fat reduction in people with obesity , perhaps … Read More